27 July 2015
Low-dose lithium reduced involuntary motor movements — the troubling side effect of the medication most commonly used to treat Parkinson’s disease (PD) — in a mouse model of the condition that is diagnosed in about 60,000 Americans each year. The third in a series of studies from involving PD and low-dose lithium, the results add to mounting evidence that low-doses of the psychotropic drug could benefit patients suffering from the incurable, degenerative condition.img src=”http://feeds.feedburner.com/~r/sciencedaily/~4/6c2OAJbTn8A” height=”1″ width=”1″ alt=””/
http://feeds.sciencedaily.com/~r/sciencedaily/~3/6c2OAJbTn8A/150727092541.htm
